Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11001841 | Thrombosis Research | 2018 | 6 Pages |
Abstract
The study demonstrated that the oral and IV administration of TXA in patients undergoing THA was proved to be an equivalent and effective method in reducing blood loss and transfusion rates. However, oral TXA is more cost-effectiveness than IV TXA, and it may be an alternative to the IV form.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yuangang Wu, Yi Zeng, Qinsheng Hu, Mingyang Li, Xianchao Bao, Jian Zhong, Bin Shen,